ARIPIPRAZOLE        SUPPORTING DATA 
Supporting data
Supported by GSK.
(c) 2004 Excerpta Medica
All rights reserved.
Disclaimer
print this page
 Guidelines

Strengths:

Well-documented efficacy in acute mania

  • Significantly more aripiprazole-treated patients responded to and continued with treatment than haloperidol-treated patients. [ICG Guidelines]
  • Following remission of an initial episode of mania, patients should be withdrawn from their benzodiazepine or antipsychotic once the acute episode has resolved. [Australian Guidelines]

Weaknesses:

Limited data available in bipolar maintenance

  • Following remission of an initial episode of mania, patients should be withdrawn from their benzodiazepine or antipsychotic once the acute episode has resolved. [Australian Guidelines]
International Consensus Group on Bipolar I Depression


 
  
home help sitemap acronyms help sitemap home